Similar articles

• Antimetastatic and antitumor effect of platelet aggregation inhibitors.

  Ambrus JL, Ambrus CM, Gastpar H, Huberman E, Montagna R, Biddle W, Leong S, Horoszewicz J. Ambrus JL, et al. Prog Clin Biol Res. 1982;89:97-111. Prog Clin Biol Res. 1982. PMID: 7111312 No abstract available.
• Platelet aggregation inhibitors and cancer metastasis.

  Gastpar H. Gastpar H. Ann Chir Gynaecol. 1982;71(3):142-50. Ann Chir Gynaecol. 1982. PMID: 6287902 Review. No abstract available.
• Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations.

  Gastpar H, Ambrus JL, Ambrus CM. Gastpar H, et al. J Med. 1981;12(1):15-33. J Med. 1981. PMID: 6943264 No abstract available.
• Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.

  Mamytbeková A, Rezábek K, Kacerovská H, Grimová J, Svobodová J. Mamytbeková A, et al. Neoplasma. 1986;33(4):417-21. Neoplasma. 1986. PMID: 3762804
• [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].

  Gastpar H. Gastpar H. Laryngol Rhinol Otol (Stuttg). 1983 Dec;62(12):578-85. Laryngol Rhinol Otol (Stuttg). 1983. PMID: 6369051 Review. German.